Chapel Hill, NC, USA..
N Engl J Med. 2011 Mar 24;364(12):1176. doi: 10.1056/NEJMc1101915. Epub 2011 Mar 2.
To the Editor: We would like to retract our article, "A Genomic Strategy to Refine Prognosis in Early-Stage Non-Small-Cell Lung Cancer,"(1) which was published in the Journal on August 10, 2006. Using a sample set from a study by the American College of Surgeons Oncology Group (ACOSOG) and a collection of samples from a study by the Cancer and Leukemia Group B (CALGB), we have tried and failed to reproduce results supporting the validation of the lung metagene model described in the article. We deeply regret the effect of this action on the work of other investigators.
我们希望撤回我们于 2006 年 8 月 10 日发表在《期刊》上的文章“一种基因组策略,用于细化早期非小细胞肺癌的预后”(1)。使用美国外科医师学院肿瘤学组(ACOSOG)研究中的样本集和癌症与白血病组 B(CALGB)研究中的样本集合,我们已经尝试但未能复制支持文章中描述的肺基因模型验证的结果。我们对这一行为对其他研究人员工作的影响深表遗憾。